Aspirin resistance.
Rouvier
Jorge
J
Scazziota
Alejandra
A
Altman
Raúl
R
D001241:Aspirin / Q000009:adverse effects*; D015415:Biomarkers / Q000652:urine; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D004351:Drug Resistance; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011237:Predictive Value of Tests; D012306:Risk; D013927:Thrombosis / Q000517:prevention & control*; D013929:Thromboxane B2 / Q000031:analogs & derivatives* / Q000652:urine; D013931:Thromboxanes / Q000378:metabolism
D015415:Biomarkers; D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013931:Thromboxanes; D013929:Thromboxane B2; C049235:11-dehydro-thromboxane B2; D001241:Aspirin